A Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer
Clinical trial NCT00885963 · TERMINATED
Trial details
- NCT number
- NCT00885963
- Sponsor
- Cyclacel Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2013-08-13
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.